The Urinalysis Market in North America is expected to grow from US$ 1,432.01 million in 2021 to US$ 2,129.13 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. The urinalysis market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launches, regional expansions, and technological advancements to expand their market share. Rising demand for rapid tests, point-of-care (PoC) testing, and portable instruments are encouraging new product launches in the urinalysis market. The PoC testing enables rapid results in non-laboratory settings, along with boosting productivity. These tests are cost-effective and encompass the diagnoses of a wide range of diseases. Moreover, the growing demand for PoC diagnostics products is further driving product innovations in the urinalysis market. Market players are readily investing in R&D to develop advanced technologies.
North America Urinalysis Market Segmentation
North America Urinalysis Market –
By Product
- Consumables
- Instruments
North America Urinalysis Market – By
Test Type
- Pregnancy and Fertility Tests
- Biochemical Urinalysis
- Sediment Urinalysis
North America Urinalysis Market – By Application
- Disease Screening
- Pregnancy and Fertility
North America Urinalysis Market – By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Research Laboratories and Institutes
North America Urinalysis Market – By Country
- US
- Canada
- Mexico
North America Urinalysis Market – Company Profiles
- Abbott
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Siemens Healthineers AG
- Sysmex Corporation
Market Overview
The North America urinalysis market is segmented into the US, Canada, and Mexico, with the US holding the largest market share. This dominance is driven by the rising prevalence of chronic diseases, the presence of key market players, and extensive research and development efforts by various laboratories and institutions. Additionally, increasing public healthcare expenditure and awareness programs are further fueling market growth.
The COVID-19 pandemic initially disrupted the market, as lockdowns across North America led to delays in routine health checkups, reducing the number of diagnostic tests performed and impacting the sales of instruments, consumables, and reagents. However, as restrictions eased, testing volumes rebounded. According to the National Kidney Foundation, patients hospitalized with COVID-19 face a heightened risk of acute kidney injury (AKI), which can lead to severe illness, dialysis, or even death. Consequently, urinalysis is recommended for recovered COVID-19 patients who experienced AKI or acute renal failure, as they are at an increased risk of developing chronic kidney disease. Even COVID-19 patients who did not experience AKI but exhibited blood or protein in their urine require monitoring due to their elevated risk of chronic and end-stage kidney disease.
The pandemic has also influenced regulatory policies, as governments and healthcare providers adapted to unprecedented challenges. Regulatory authorities expedited the approval of diagnostic products, and companies implemented strategic initiatives to introduce COVID-19 rapid tests, stabilize revenue, and maintain operational efficiency. For instance, in August 2020, Sysmex America, Inc. entered a distribution agreement with Siemens Healthineers to expand the reach of the CLINITEK Novus automated urine chemistry analyzer platform. As vaccination programs progress and transmission rates decline, the healthcare industry is expected to stabilize, driving renewed demand for urinalysis products and services.
Strategic Insights: North America Urinalysis Market
The North America urinalysis market presents significant opportunities for growth, with data-driven insights highlighting emerging trends, key players, and regional dynamics. These insights enable businesses to gain a competitive edge by identifying untapped market segments and developing unique value propositions. By leveraging data analytics, industry players—including investors, manufacturers, and other stakeholders—can anticipate market shifts and strategically position themselves for long-term success.
A forward-thinking approach is crucial in this dynamic market, as it allows stakeholders to navigate evolving industry trends and regulatory landscapes effectively. Ultimately, well-informed strategic decisions will drive profitability, enhance market positioning, and support business objectives in the expanding North America urinalysis market.
Other Reports:
North America Multiple Sclerosis Therapeutics Market: https://www.quora.com/profile/Business-Market-Insights-1/North-America-Multiple-Sclerosis-Therapeutics-Market-2027-Size-Share-Industry-Trends-Business-Revenue-Forecast-and-S
North America Artificial Intelligence in Market: https://penzu.com/p/6a525833f613cd65
North America Long Read Sequencing Market: https://postyourarticle.com/north-america-long-read-sequencing-market-analysis-trends-share-development-policies-and-future-growth-2028/
North America Stevia Market: https://sites.google.com/view/north-america-long-read-sequen/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
